Advent of auto-titrating CPAP machines has become a game-changer in sleep apnea devices market. The report “Global Sleep Apnea Market (By Products - Diagnostics & Therapeutics; By Region – North America-The US; Europe-The UK & Germany; Asia Pacific-China & India; Latin America) Outlook 2024” provides information on the current scenario, market outlook of the global sleep apnea market with detailed analysis of market segments such as Diagnostics & Therapeutics. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe, Asia Pacific and Latin America. Market outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global sleep apnea market. The report has been segmented as following:-
Market Segments
• Diagnostics
• Therapeutics
Geographical Coverage
• North America - The US
• Europe – The UK & Germany
• Asia Pacific – China & India
• Latin America
Companies Coverage
• ResMed Inc.
• Fisher & Paykel Healthcare
• Philips Respironics
• CareFusion
Sleep Apnea is a life-threatening sleep disorder characterized by abnormal pauses in breathing. It is caused by caused by either complete obstruction of the airway (obstructive apnea) or partial obstruction (obstructive hypopnea). There are three types of sleep apnea — obstructive, central, and mixed. Obstructive sleep apnea (OSA) is the most common type of sleep apnea. This condition is found to be more prevalent in elderly population and is often stimulated by lifestyle related chronic diseases such as cardiovascular diseases and obesity.
Growth of global sleep apnea devices market is primarily attributed to prevalence of sleep apnea, high incidence of lifestyle-related chronic diseases, increasing obesity, rising demand in emerging markets and increasing geriatric population. However, some of the factors restraining growth of the industry are stringent regulatory norms and high cost of devices.
The report “Global Sleep Apnea Market (By Products - Diagnostics & Therapeutics; By Region – North America-The US; Europe-The UK & Germany; Asia Pacific-China & India; Latin America) Outlook 2024” provides information on the current scenario, market outlook of the global sleep apnea market with detailed analysis of market segments such as Diagnostics & Therapeutics. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe, Asia Pacific and Latin America. Future forecasts of sleep apnea treatment market overall and across various sub-segments has been provided till 2024, for all the geographies. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global sleep apnea market includes ResMed Inc., Fisher & Paykel Healthcare, Philips Respironics, CareFusion, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as regional sleep apnea market.
1. Executive Summary
2. Research Methodology
3. Sleep Apnea
3.1 Overview
3.2 Classification
3.2.1 Obstructive Sleep Apnea (OSA)
3.2.2 Mixed Sleep Apnea
3.2.3 Central Sleep Apnea (CSA)
3.3 Diagnosis & Treatment
3.3.1 Continuous Positive Airway Pressure (CPAP)
3.3.2 Other Airway Pressure Devices
3.3.3 Surgical Option
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Type
4.2.2 Market Share by Product
4.2.3 Market Share by Region
5. Market Segmentation
5.1 Therapeutic Devices
5.1.1 Continuous Positive Airway Pressure (CPAP)
5.1.2 Oral Appliances
5.2 Diagnostic Devices
5.2.1 Polysomnography Devices (PSG)
6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.1.2.1 Market Sizing (Actual & Forecasted)
6.1.2.2 Market Share by Products
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Germany
6.2.2.1 Market Sizing (Actual & Forecasted)
6.2.2.2 Market Share by Type of Device
6.2.3 The UK
6.2.3.1 Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
6.3.2 China
6.3.2.1 Market Sizing (Actual & Forecasted)
6.3.3 India
6.3.3.1 Market Sizing (Actual & Forecasted)
6.4 Latin America
6.4.1 Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trends & Developments
7.1.1 Home Testing for Sleep Apnea
7.1.2 Advent of Auto-titrating CPAP
7.3 Growth Drivers
7.3.1 Prevalence of Sleep Apnea
7.3.2 Higher Incidence of Lifestyle-Related Chronic Diseases
7.3.3 Increasing Obesity
7.3.4 Rising Demand in Emerging Markets
7.3.5 Increasing Geriatric Population
7.4 Challenges
7.4.1 High Cost of Device
7.4.2 Stringent Regulatory Norms
8. Competitive Landscape
8.1 Comparative Analysis
8.2 Market Share Analysis
8.2.1 Global
8.2.2 Regional
9. Company Profiles
9.1 ResMed Inc.
9.2 Fisher & Paykel Healthcare
9.3 Philips Respironics
9.4 CareFusion
List of Tables
Table 1: Sleep Apnea Device Manufacturers Competitive Landscape
Table 2: Global Sleep Apnea Market Players Financial Analysis
List of Figures
Figure 1: Rockville Research – Research Methodology
Figure 2: Classification of Sleep Apnea
Figure 3: Components of Sleep Apnea Device
Figure 4: Global Sleep Apnea Devices Market Size by Value, 2016-22E (US$ Billions)
Figure 5: Global Sleep Apnea Market by Type (2017)
Figure 6: Global Sleep Apnea Market Share by Product (2018)
Figure 7: Global Sleep Apnea Devices Market Share by Region (2017)
Figure 8: OSA Prevalence by Nations (2017)
Figure 9: Global Sleep Apnea Therapeutic Devices Market Size by Value, 2017-24E (US$ Billions)
Figure 10: Global Sleep Apnea CPAP Market Size by Value, 2017-24E (US$ Millions)
Figure 11: Global Sleep Apnea Oral Appliances Market Size by Value, 2017-24E (US$ Millions)
Figure 12: Global Sleep Apnea Diagnostic Devices Market Size by Value, 2017-24E (US$ Billions)
Figure 13: Global Sleep Apnea – Polysomnography Devices (PSG) Market Size by Value, 2017-24E (US$ Millions)
Figure 14: North America Sleep Apnea Market Size by Value, 2017-24E (US$ Billions)
Figure 15: The US Sleep Apnea Market Size by Value, 2012-22E (US$ Millions)
Figure 16: The US Undiagnosed Obstructive Sleep Apnea Economic Costs (2016)
Figure 17: The US Sleep Apnea Market Share by Product (2017)
Figure 18: The US Sleep Apnea Therapeutics Device Market Share by Product (2017)
Figure 19: Europe Sleep Apnea Market Size by Value, 2017-24E (US$ Billions)
Figure 20: Germany Sleep Apnea Market Size by Value, 2012-22E (US$ Millions)
Figure 21: Germany Sleep Apnea Market Share by Type of Device (US$ Millions)
Figure 22: The UK Sleep Apnea Market Size by Value, 2017-24E (US$ Millions)
Figure 23: Asia Pacific Sleep Apnea Market Size by Value, 2017-24E (US$ Billions)
Figure 24: China Sleep Apnea Market Size by Value, 2017-24E (US$ Millions)
Figure 25: India Sleep Apnea Market Size by Value, 2017-24E (US$ Millions)
Figure 26: Latin America Sleep Apnea Market Size by Value, 2017-22E (US$ Billions)
Figure 27: Global Sleep Apnea Incidences, 2007-18 (Millions)
Figure 28: Prevalence of Sleep Apnea in Comorbidities (%)
Figure 29: Global Obese Population, 2012-18E (Millions)
Figure 30: Global Ageing Population, 2012-18E (Millions)
Figure 31: Global Sleep Apnea Market Share by Competitors (2018)
Figure 32: Asia Pacific Sleep Apnea Market Share by Competitors (2018)
Figure 33: ResMed Inc. Revenue by Business Segment (FY2017)
Figure 34: ResMed Inc. Net Sales, FY2013-FY2017 (US$ Billions)
Figure 35: Fisher & Paykel Healthcare Revenue by Business Segment (FY2017)
Figure 36: Fisher & Paykel Healthcare Net Sales, FY2013-FY2017 (US$ Billions)
Figure 37: Philips Respironics Revenue by Business Segment (FY2017)
Figure 38: Philips Respironics Net Sales, FY2013-FY2017 (US$ Billions)
Figure 39: CareFusion Revenue by Business Segment (FY2017)
Figure 40: CareFusion Net Sales, FY2013-FY2017 (US$ Billions)
ResMed Inc., Fisher & Paykel Healthcare, Philips Respironics, CareFusion
*If Applicable.